Penumbra's Lightning Flash Launch Pushed Into Next Year, Trims FY22 Forecasts

  • Penumbra Inc PEN posted Q3 FY22 revenue of $213.7 million, +12.4% Y/Y (up 15.1% in constant currency), beating the consensus of $212.28 million.
  • Revenue from sales of vascular products grew 17% (18.8%) to $123.4 million. 
  • Revenue from sales of neuro products grew 6.7% (10.5%) to $90.3 million.
  • The gross margin was almost stagnant at 63%.
  • The company reported an adjusted operating income of $7.8 million, down from $8.8 million posted a year ago.
  • The company reported an adjusted EPS of $0.01, down from $0.12 a year ago.
  • The company's Lightning Flash product launch is expected in Q1 2023, six weeks later than the previous mid-Q4 2022 estimate, and an incremental headwind of $4-6 million from foreign currency translations.
  • Guidance: Penumbra expects 2022 total revenue of $840-$845 million, up 12-13% Y/Y (15-16% in constant currency), down from previous guidance of $860-$875 million and the consensus of $860.97 million.
  • Looking forward to 2023, the company expects to achieve a $1 billion total revenue.
  • Price Action: PEN shares closed 3.5% lower at $151.88 on Thursday.
Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapNewsGuidanceHealth CareGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!